BioCentury
ARTICLE | Clinical News

AVR118: Phase II start

September 10, 2007 7:00 AM UTC

ADVR plans to start a Phase II trial of AVR118 in 14 cancer patients with cachexia-related symptoms. Pending the results from this first cohort, the trial could enroll at least 32 patients. ...